What is the current Global Gastroparesis Drug Market size?

The Global Gastroparesis Drug Market is projected to register a CAGR of 4.5% during the forecast period (2024-2029) Read More

Who are the key players in Global Gastroparesis Drug Market?

Evoke Pharma, AstraZeneca, Cadila Pharmaceuticals, Neurogastrx, Inc. and AbbVie Inc. ( Allergan Plc) are the major companies operating in the Global Gastroparesis Drug Market. Read More

Which is the fastest growing region in Global Gastroparesis Drug Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Gastroparesis Drug Market?

In 2024, the North America accounts for the largest market share in Global Gastroparesis Drug Market. Read More

What years does this Global Gastroparesis Drug Market cover?

The report covers the Global Gastroparesis Drug Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Gastroparesis Drug Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Gastroparesis Drug Market Size & Share Analysis - Industry Research Report

Gastroparesis Drug Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Gastroparesis Drug Market is Segmented by Drug Class (Antiemetic Agents, Prokinetic Agents, and Botulinum Toxin Injections), Disease Type (Diabetic Gastroparesis, Post-Surgical Gastroparesis, Idiopathic Gastroparesis, and Other Disease Types), End User (Hospitals, Clinics, and Pharmacies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Gastroparesis Drug Industry Overview

The market is consolidated in nature due to the presence of very limited players operating globally. Some companies currently dominating the market are Abbott Laboratories (Abbott Arzneimittel GmbH), AbbVie Inc. (Allergan Plc), Cadila Pharmaceuticals, Evoke Pharma, AstraZeneca Plc, Neurogastrx Inc., Bausch Health, Theravance Biopharma, and GlaxoSmithKline Plc.